Drug developers will now have enhanced abilities to rapidly prototype, test, iterate, and scale up their mRNA therapeutics.

Key to 400-employee Denali's submission is the FDA allowing measurement of a type of GAG, called heparan sulfate, in ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

Three other Bay Area companies — Mirum Therapeutics Inc. (Nasdaq: MIRM), Soleno Therapeutics Inc. (Nasdaq: SLNO) and Exelixis ...

Received FDA authorization and recorded first commercial sales of ARC-EX SystemSecured strategic investment from Ottobock and extended cash ...

Incorrect wall and David Raya’s poor positioning: The free-kick that caught out Arsenal Portuguese’s controversial free-kick appeared to be aided by both the unusual positioning of the wall ...

The decision came after the discovery of a problem with the methodology used in these data sets. The issue impacts data from the year 2008 onward, but the most significant effect on annual producer ...

Onward Robotics Showcases Innovative Meet Me® Solution for Automated Order Fulfillment With Live Demonstrations at ProMat 2025 "We're on a mission to revolutionize fulfillment, helping ...

Check Out Our Latest Analysis on United Therapeutics United Therapeutics Stock Down 1.6 % UTHR stock opened at $313.60 on Wednesday. United Therapeutics has a 52-week low of $221.53 and a 52-week ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Nurix Therapeutics, Inc. has a 1-year low of $11.90 and a 1-year high of $29.56. The company has a market cap of $1.05 billion, a price-to-earnings ratio of -4.81 and a beta of 2.18.